Lymphoma

The world-renowned experts at the OSUCCC – James are transforming the way blood cancers are prevented, detected, treated and, yes, cured.

Today, cancer is no longer solely defined by location or even by stage. We know there is no routine cancer, and there is no routine lymphoma.

Lymphoma is a complex disease. Each patient’s disease is different, behaving differently in the bodies they’re in and calling for a tailored, individualized treatment plan for each patient.

To deliver the most effective lymphoma detection and treatment, our nationally renowned experts identify and understand cancer at the biologic and genetic levels, unlocking the molecular code of a patient’s disease and pinpointing what makes each cancer grow — then discovering what stops it.

Our team of lymphoma subspecialists spans a broad range of disciplines: from hematology and radiation oncologists to molecular and biological pathologists, genetic scientists and more — all specializing in lymphoma (and only lymphoma) research, prevention, detection, treatment and cure.

It’s that subspecialization and singular focus that enable us to discover, develop and deliver the most targeted therapies for each individual lymphoma patient.

And that means our collective expertise leads to improved outcomes, faster responses, fewer side effects and more hope for cancer patients everywhere.

Cutaneous lymphoma is a rare type of non-Hodgkin’s lymphoma (NHL). It is usually less aggressive than other lymphomas, and it tends to stay in the skin instead of spreading into the lymph nodes, bone marrow or spleen. The OSUCCC – James is a leader in offering some of the world’s most advanced and sophisticated, successful treatments for cutaneous lymphoma patients.

Hodgkin’s lymphoma occurs when a cancer cell, known as the Reed-Sternberg cell, spreads from one part of the lymph system to another and then into other organs. Hodgkin’s lymphoma is an extremely rare kind of lymphoma, accounting for less than one percent of all diagnosed cancers in the U.S. The OSUCCC – James team of experts analyzes the genetic and biological composition of each patient’s cancer to determine the best possible treatment, offering improved outcomes, faster responses and fewer side effects.

Non-Hodgkin’s lymphoma, NHL, is a blood cancer that develops in the lymphatic system, which is part of the body’s immune system. Today, advanced radiation, targeted combination therapies and new treatments discovered by the OSUCCC – James subspecialists and other experts around the world mean that most cases of newly diagnosed NHL cases are curable, especially if diagnosed early.